PerPlexity Biotechnology JP's Stock Coverage
| 4893Noile-Immune Biotech Inc. | Nov 06, 2026 | SELL | Downgraded | ¥80.00 | 154Ratings | -3.40% | ||
| 4599StemRIM Inc. | Nov 06, 2026 | SELL | Reiterated | ¥116.00 | 52Ratings | +25.50% | ||
| 4588Oncolys BioPharma, Inc. | Nov 06, 2026 | HOLD | Reiterated | ¥7,490.00 | 107Ratings | -49.63% | ||
| 7776CellSeed Inc. | Nov 05, 2026 | HOLD | Reiterated | ¥174.00 | 74Ratings | +9.15% | ||
| 6190PhoenixBio Co., Ltd. | Nov 05, 2026 | HOLD | Reiterated | ¥278.00 | 130Ratings | -2.83% | ||
| 4978ReproCELL Inc. | Nov 05, 2026 | HOLD | Reiterated | ¥114.00 | 50Ratings | ― | ― | |
| 4883Modalis Therapeutics Corporation | Nov 05, 2026 | HOLD | Reiterated | ¥24.50 | 36Ratings | ― | ― | |
| 4881FunPep Company Limited | Nov 05, 2026 | HOLD | Reiterated | ¥39.00 | 119Ratings | +11.60% | ||
| 4591Ribomic, Inc. | Nov 05, 2026 | HOLD | Reiterated | ¥60.00 | 46Ratings | ― | ― | |
| 4584Kidswell Bio Corporation | Nov 05, 2026 | HOLD | Reiterated | ¥146.00 | 94Ratings | ― | ― |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >PerPlexity Biotechnology JP activity FAQ
What is the performance of PerPlexity Biotechnology JP's recommendations?
The percentage of profitable recommendations made by PerPlexity Biotechnology JP is 45.24%, and the average return per transaction is 5.10%.
What stocks does PerPlexity Biotechnology JP cover?
PerPlexity Biotechnology JP mostly covers Oncolys BioPharma, Inc., StemRIM Inc., Noile-Immune Biotech Inc. stocks.
What was PerPlexity Biotechnology JP's most profitable rating?
PerPlexity Biotechnology JP’s most profitable rating was a buy on Immuno-Biological Laboratories Co., Ltd. stock on Jul 23, 2025. The return on the trade was 315.40%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here